Kopran Ltd. Financials

10:14 Jun 19

Kopran Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
188.00
-2.48 (-1.30%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Kopran Ltd. Financials

Kopran Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
188.00
-2.48 (-1.30%)
10:14 Jun 19
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

4

Weakness

4

Opportunity

1

Threats

0

7.43 %

ROE %

4.56 %

ROA %

7.98

EPS

107.35

BVPS

6.10 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
491.81 477.52 550.99 614.59 631.9
Operating Expenses +
410.03 390.13 499.2 540.18 556.71
Raw Material
286.27 300.56 345.95 400.88 410.66
Increase Decrease in Cost
15.52 -29.19 12.62 1.06 -6.04
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
37.16 43.27 49.95 52.28 60.54
Miscellaneous Expenses
112.72 81.95 139.36 98.02 110.87
Operating Profit
81.78 87.39 51.79 74.41 75.19
Other Income
17.99 10.6 3.06 14.61 1.69
Depreciation
10.19 11.1 12.71 12.89 15.59
Interest
6.24 5.12 6.08 8.59 9.34
Profit before tax and exceptio..
83.34 81.78 36.07 67.54 51.95
Exceptional Items
0 0 0 0 0
PBT
83.34 81.78 36.07 67.54 51.95
Provision for Taxation
21.73 20.75 8.83 16.59 13.4
Net Profit
61.61 61.03 27.23 50.96 38.55
NET Profit after MI
61.61 61.03 27.23 50.96 38.55
EPS
14.24 13.77 5.65 10.57 7.99
Operating Profit Margin (%)
16.63 18.3 9.4 12.11 11.9
Net Profit Margin (%)
12.53 12.78 4.94 8.29 6.1

Kopran Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 44.40 44.50 44.50 44.50 44.50
FII 1.10 0.90 1.30 0.70 0.80
MF 0.00 0.00 0.00 0.00 0.90
Others 0.00 -0.10 0.20 0.10 0.30
Shareholder Shares Holding %
Download Our App On: